Prkaa2 Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Prkaa2
protein kinase, AMP-activated, alpha 2 catalytic subunit
MGI:1336173

40 phenotypes from 4 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Prkaa2^tm1.1Sjm/Prkaa2^tm1.1Sjm Tg(Tek-cre)1Ywa/0 involves: C57BL/6 * SJL	pulmonary hypertension	J:286356
Prkaa2^tm1.1Vio/Prkaa2^tm1.1Vio involves: 129S2/SvPas	abnormal muscle cell glucose uptake	J:87719
	decreased circulating insulin level	J:87719
	decreased skeletal muscle glycogen level	J:87719
	impaired glucose tolerance	J:87719
Prkaa2^tm1.1Vio/Prkaa2^tm1.1Vio involves: 129S2/SvPas * C57BL/6	abnormal glucose homeostasis	J:81120
	abnormal glycogen homeostasis	J:81120
	abnormal sympathetic nervous system physiology	J:81120
	abnormal urine catecholamine level	J:81120
	decreased circulating insulin level	J:81120
	decreased circulating leptin level	J:81120
	decreased insulin secretion	J:81120
	decreased skeletal muscle glycogen level	J:81120
	normal homeostasis/metabolism phenotype	J:81120
	hyperglycemia	J:81120
	impaired glucose tolerance	J:81120
	increased circulating free fatty acids level	J:81120
	insulin resistance	J:81120
Prkaa2^{tm1b(EUCOMM)Hmgu}/Prkaa2^{tm1b(EUCOMM)Hmgu} C57BL/6N-Prkaa2^{tm1b(EUCOMM)Hmgu}/H	decreased circulating alkaline phosphatase level	J:211773
	decreased circulating fructosamine level	J:211773
	decreased circulating serum albumin level	J:211773
	decreased exploration in new environment	J:211773
	decreased fasting circulating glucose level	J:211773
	enlarged spleen	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	increased circulating creatine kinase level	J:211773
Prkaa2^tm1Vio/Prkaa2^tm1Vio Tg(Agrp-cre)1Gsb/0 involves: 129S2/SvPas * FVB/N	abnormal neuron physiology	J:123951
	decreased body weight	J:123951
	enhanced behavioral response to xenobiotic	J:123951
	normal homeostasis/metabolism phenotype	J:123951
Prkaa2^tm1Vio/Prkaa2^tm1Vio Tg(Alb1-cre)7Gsc/0 involves: 129S2/SvPas * FVB/N	abnormal gluconeogenesis	J:108399
	abnormal glucose homeostasis	J:108399
	impaired glucose tolerance	J:108399
	increased circulating adiponectin level	J:108399
	increased circulating glucose level	J:108399
	increased circulating insulin level	J:108399
	increased circulating leptin level	J:108399
	increased fatty acids level	J:108399
	increased triglyceride level	J:108399
Prkaa2^tm1Vio/Prkaa2^tm1Vio Tg(Pomc1-cre)1Gsb/0 involves: 129S2/SvPas * FVB/N	abnormal metabolism	J:123951
	abnormal neuron physiology	J:123951
	increased body weight	J:123951
	increased compensatory feeding amount	J:123951
	increased percent body fat/body weight	J:123951
	increased susceptibility to diet-induced obesity	J:123951
	normal nervous system phenotype	J:123951

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/23/2024 MGI 6.23